Global Health Limited — Investor Meet, 15-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Global Health Limited (Medanta) has announced a board meeting to discuss the financial results for the quarter and half-year.

Revenue for FY25 grew 12.6% YoY to INR 3,771 Cr, EBITDA rose 9.4% to INR 956 Cr with 25.4% margin, and PAT was INR 481 Cr (adjusted PAT up 8.5% YoY to INR 519 Cr after a one-time merger cost). Occupied bed days increased 10%, adding 219 new beds; mature and developing hospitals saw near 10% revenue growth. Q4 saw 14.1% revenue growth to INR 954 Cr with a 26% EBITDA margin. Expansion plans include ~3,000 new beds across several cities over five years with planned capex of INR 3,500 Cr. Net cash stands at INR 812 Cr. Focus remains on volume growth, efficiency, and integrated patient care.